BRUKER CORPORATION Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
BRUKER CORPORATION (BRKR) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of -$500.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2025-03-03.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2025-03-03
- BRUKER CORPORATION valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was -$500.00K, a 200.00% decline from fiscal 2021.
- BRUKER CORPORATION valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2021 was $500.00K.
- BRUKER CORPORATION valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2019 was -$100.00K, a 107.69% decline from fiscal 2018.
- BRUKER CORPORATION valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2018 was $1.30M.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|
| 2022-12-31 | -$500.00K 10-K · filed 2025-03-03 | |
| 2021-12-31 | $500.00K 10-K · filed 2023-03-01 | |
| 2019-12-31 | -$100.00K 10-K · filed 2022-02-28 | |
| 2018-12-31 | $1.30M 10-K · filed 2021-03-01 | |
| 2017-12-31 | -$500.00K 10-K · filed 2020-03-27 | |
| 2016-12-31 | -$36.70M 10-K · filed 2018-03-16 | |
| 2015-12-31 | -$36.70M 10-K · filed 2019-03-01 | -$20.10M 10-K · filed 2016-02-29 |
| 2014-12-31 | $15.00M 10-K · filed 2017-03-01 | |
| 2013-12-31 | $2.50M 10-K · filed 2014-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |